Close Asset Management
IMCR icon

Close Asset Management’s Immunocore IMCR Stock Holding History

Close Asset Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-10,100
Closed -$321K – 265
2026
Q2 		$321K Hold
10,100
– – 0.01% 109
2026
Q1 		$304K Buy
+10,100
New +$327K 0.01% 122

Other funds holding IMCR

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Fulcrum Asset Management
Fulcrum Asset Management London, United Kingdom $2.14B AUM 54.66% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Commonwealth of Pennsylvania Public School Employees Retirement System
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $21.9B AUM 28.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Crossmark Global Holdings
Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return

Close Asset Management's IMCR Position: Q3 2026 in Review

Close Asset Management sold out of Immunocore (IMCR) in Q3 2026, closing a stake of 10,100 shares — an estimated $321K sold.

Close Asset Management first reported a position in IMCR in Q1 2026 and held it in 2 quarters. The position peaked at $321K in Q2 2026. 36 funds tracked by Wall St. Rank hold IMCR as of Q3 2026.

  • Close Asset Management reported no remaining Immunocore position as of Q3 2026 after selling out during the quarter.
  • Close Asset Management sold 10,100 Immunocore shares in Q3 2026, an estimated $321K.
  • Close Asset Management first reported a position in Immunocore in Q1 2026 and held it in 2 quarters.
  • Close Asset Management's Immunocore position peaked at $321K in Q2 2026.
  • 36 funds tracked by Wall St. Rank held Immunocore as of Q3 2026.

Based on Close Asset Management's 13F filing for Q3 2026, filed 30 Oct 2026.